NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional […]
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged
Terry Ward, CEO of Country Communities, is proud to announce the sale of six additional homesites at Townsend Reserve, a significant milestone for the company's 19th development. The buyer of these six home sites is Murphy Yates Signature Homes. With these six newly sold lots and an additional six lots under contract, Murphy Yates Signature
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Open Lending Corporation ("Open Lending" or "the Company") (NASDAQ:LPRO). Investors who purchased Open Lending securities prior to February 24, 2022, and continue to hold to the present, are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities prior to March 13, 2023, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain
NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ:EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXEL. Investigation Details
NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information